Prognostic benefit of conversion surgery for HER2 positive stage IV gastric cancer; a case series study of eleven patients treated with trastuzumab-based chemotherapy

Prognostic benefit of conversion surgery for HER2 positive stage IV gastric cancer; a case series study of eleven patients treated with trastuzumab-based chemotherapy

Abstract Background Since the ToGA trial, trastuzumab-based chemotherapy is the standard treatment for HER2 positive stage IV gastric cancer. However, it is not yet clear whether surgical resection after trastuzumab-based chemotherapy (conversion surgery) can improve survival of HER2 positive stage...

Full description

Bibliographic Details
Main Authors: Koichi Hayano, Hiroki Watanabe, Takahiro Ryuzaki, Naoto Sawada, Gaku Ohira, Masayuki Kano, Masaya Uesato, Hisahiro Matsubara
Format: Article
Language:English
Published: SpringerOpen 2020-09-01
Series:Surgical Case Reports
Subjects:
Gastric cancer
Human epidermal growth factor receptor-2
Conversion surgery
Trastuzumab
Online Access:http://link.springer.com/article/10.1186/s40792-020-00984-w

Internet

http://link.springer.com/article/10.1186/s40792-020-00984-w

Similar Items